CATEGORY

Medical Writing Services

Beroe LiVE.Ai™

AI-powered self-service platform for all your sourcing decision needs across 1,600+ categories llike Medical Writing Services.

Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.

Schedule a Demo

Medical Writing Services Market Monitoring Dashboard


Supply Demand

Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™

Medical Writing Services Industry Benchmarks


Savings Achieved

(in %)

The average annual savings achieved in Medical Writing Services category is 5.40%

Payment Terms

(in days)

The industry average payment terms in Medical Writing Services category for the current quarter is 60.0 days

Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™

Category Strategy and Flexibility

Engagement Model

Supply Assurance

Sourcing Process

Supplier Type

Pricing Model

Contract Length

SLAs/KPIs

Lead Time

Supplier Diversity

Targeted Savings

Risk Mitigation

Financial Risk

Sanctions

AMEs

Geopolitical Risk

Cost Optimization

Price per Unit Competitiveness

Specification Leanness

Minimum Order Quality

Payment Terms

Inventory Control

Meet Abi

The World’s first Digital Market Analyst

    Schedule a Demo
    Meet Abi

    The World’s first Digital Market Analyst

    Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions

    Medical Writing Services Suppliers


    Medical Writing Services Supplier

    Find the right-fit medical writing services supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.

    Sample Supplier
    Company
    IQVIA HOLDINGS INC.
    Location
    Jackson, Mississipi
    Duns number
    3862211

    D&B SER Rating

    dnb logo

    Up to 3 months

    1 9
    4
    Low Risk High Risk

    The Supplier Evaluation Risk (SER) Rating is Dun & Bradstreet’s proprietary scoring system used to assess the probability that a business will seek relief from creditors or cease operations within the next 12 months. SER ratings range from 1 to 9, with 9 indicating the highest risk of failure. We’ve prepared an infographic to help business owners better understand what influences their SER Rating.

    Moody`s ESG Solution
    ESG Profile

    Company and Sector Performance
    36

    100
    Limited (1)
    ESG Perfomance (/100)
    Environment
    41
    Social
    30
    Governance
    43
    6 Domains Performance (/100)
    Business behaviour
    48
    Human rights
    39
    Community Environment
    31
    Corporate governance
    40
    Human resources
    22
    Security Scorecard
    77

    Threat indicators
    C
    75
    Network Security
    Detecting insecure network settings
    A
    100
    Hacker Chatter
    Monitoring hacker sites for chatter about your company
    D
    63
    DNS Health
    Detecting DNS insecure configuration and vulnerabilities
    C
    70
    Application Security
    Detecting common website application vulnerbilities
    C
    77
    Endpoint Security
    Detecting unprotected enpoints or entry points of user tools, such as desktops, laptops mobile devices, and virtual desktops
    A
    100
    Cubic Score
    Proprietary algorithms checking for implementation of common security best practices
    D
    60
    Patching Cadence
    Out of date company assets which may contain vulnerabilities of risk
    A
    100
    Social Engineering
    Measuring company awareness to a social engineering or phising attack
    A
    100
    IP Reputation
    Detecting suspecious activity, such as malware or spam, within your company network
    A
    100
    Information Leak
    Potentially confidential company information which may have been inadvertently leaked

    Industry Comparison
    iqvia.com
    Industry average
    Adverse Media Appearances
    Environmental Issues
    0
    Workforce Health Safety Issues
    0
    Product Service Issues
    1
    Human Rights Issues
    0
    Production Supply Chain Issues
    0
    Environmental Non Compliance Flags
    1
    Corruption Issues
    0
    Regulatory Non Compliance Flags
    2
    Fraud Issues
    0
    Labor Health Safety Flags
    0
    Regulatory Issues
    2
    Workforce Disputes
    0
    Sanctions
    0
    esg energy transition
    28
    Discrimination Workforce Rights Issues
    0
    esg controversies critical severity
    No

    Medical Writing Services market report transcript


    Medical Writing Services Global Market Outlook:

    CDM service is moving toward the next sourcing contract cycle, where the focus is expected to be on value-added services, risk-based monitoring, cycle time, cloud, etc.

    KEY MARKET DRIVERS

    • Risk-based monitoring, adaptive trials
    • Bundling of services Integration of Big Data analytics and application of AI

    Porter's Analysis on Medical Writing Services

    Supplier Power

    • Most of the regional markets are concentrated
    • In India, the top ITEs/BPOs have more than 90 percent of the market. So, it is highly concentrated
    • In North America and Western Europe, the supply market is fairly concentrated with large CROs holding most of the market share

    Barriers to New Entrants

    Upfront capital need: Server licenses and environment are typically cost prohibitive for smaller companies
    • Specialized staffs are difficult to recruit, especially in emerging markets, where demand leads supply of qualified staff by a factor of 1.2–1.5
    • Presence of dominant suppliers in the market

    Intensity of Rivalry

    • CROs and ITEs/BPOs are the major players in the market and compete on different parameters

    • BPOs, like Accenture, engage with pharma companies as a partner (long- term contracts, joint governance, scope for scale-up, etc.), whereas CROs compete, based on their therapeutic expertise

    Threat of Substitutes

    • As the industry is highly technical, the availability of substitutes is less, and hence, functional CROs offering data management services are at a lesser threat
    • EDC vendors, like Medidata, are capable of replacing CDM services in a few years, if they expand their service offerings

    Buyer Power

    • Large volume offered by large pharmaceutical companies can increase their bargaining power, due to high leverage of the former compared to mid/small pharmaceutical companies